Informations générales (source: ClinicalTrials.gov)
COVID-19 Patient Cohort: Retinal Damage in Non-invasive Retinal Imaging (OCTA)
Observational
Centre Hospitalier Intercommunal Creteil (Voir sur ClinicalTrials)
novembre 2021
décembre 2024
29 juin 2024
The objective of this research is to build a collection of non-invasive retinal imaging
(OCT and OCTA) in order to investigate the incidence and impact of retinal damage in
patients who have or have had COVID-19.
Etablissements
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CHI DE CRETEIL | Alexandra MIERE, MD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Age ≥ 18 years old
- Diagnosis of COVID-19 proven on RT-PCR, antigenic test or chest CT scan
- Affiliation to the general social security system
- A consent signed by the patient
- Age ≥ 18 years old
- Diagnosis of COVID-19 proven on RT-PCR, antigenic test or chest CT scan
- Affiliation to the general social security system
- A consent signed by the patient
- Refusal of patient participation